RMDResMed Inc.

$35B

Q4 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$770M+9.3% YoY

Gross Profit

$449M58.3% margin

Operating Income

$223M29.0% margin

Net Income

$178M23.1% margin

EPS (Diluted)

$1.22

QoQ Revenue Growth

+0.1%

Cash Flow

Operating Cash Flow

$330M

Free Cash Flow

$309M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$4.6B

Total Liabilities

$2.1B

Stockholders' Equity

$2.5B

Cash & Equivalents

$463M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$770M	$705M	+9.3%
Gross Profit	$449M	$418M	+7.5%
Operating Income	$223M	$121M	+84.4%
Net Income	$178M	$69M	+158.5%

Revenue Segments

Devices And Masks

$679M88%

Software As Service

$91M12%

RMD Q4 2020 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena